Sandoz Shuffles Management And Sets Out Restructuring Plans
As ‘Fantastic Progress’ On Biosimilars Drives Sales Growth Of Almost A Tenth In Q2
Sandoz has revealed senior management changes and details of a restructuring plan to drive efficiencies, as the firm unveiled positive results for the second quarter of 2024 that saw biosimilars continue to drive solid growth for the company.
